223 related articles for article (PubMed ID: 37533888)
1. Serum BDNF levels and state anxiety are associated with somatic symptoms in patients with panic disorder.
Li J; Li R; Li D; Zhang J; Luo X; Zhang Y
Front Psychiatry; 2023; 14():1168771. PubMed ID: 37533888
[TBL] [Abstract][Full Text] [Related]
2. Serum BDNF levels are involved in the diagnosis and treatment response in patients with PD.
Li R; Li J; Liu Y; Li D; Chu L; Zhang J; Luo X; Zhang Y
J Affect Disord; 2023 Apr; 327():31-37. PubMed ID: 36739005
[TBL] [Abstract][Full Text] [Related]
3. CREB1 and BDNF gene polymorphisms are associated with early treatment response to escitalopram in panic disorder.
Yang J; Li S; Lv H; Wang W; Zhang J; Chu L; Zhang Y
J Affect Disord; 2021 Jan; 278():536-541. PubMed ID: 33017682
[TBL] [Abstract][Full Text] [Related]
4. The Relationship Among BDNF Val66Met Polymorphism, Plasma BDNF Level, and Trait Anxiety in Chinese Patients With Panic Disorder.
Chu L; Sun X; Jia X; Li D; Gao P; Zhang Y; Li J
Front Psychiatry; 2022; 13():932235. PubMed ID: 35815047
[TBL] [Abstract][Full Text] [Related]
5. Effects of Cytochrome P450 2C19 Genetic Polymorphisms on Responses to Escitalopram and Levels of Brain-Derived Neurotrophic Factor in Patients With Panic Disorder.
He Q; Mei Y; Liu Y; Yuan Z; Zhang J; Yan H; Shen L; Zhang Y
J Clin Psychopharmacol; 2019; 39(2):117-123. PubMed ID: 30742590
[TBL] [Abstract][Full Text] [Related]
6. Differences in cytokines between patients with generalised anxiety disorder and panic disorder.
Zou Z; Zhou B; Huang Y; Wang J; Min W; Li T
J Psychosom Res; 2020 Jun; 133():109975. PubMed ID: 32220649
[TBL] [Abstract][Full Text] [Related]
7. Associations between brain-derived neurotrophic factor and cognitive impairment in panic disorder.
Wang W; Liu Y; Luo S; Guo X; Luo X; Zhang Y
Brain Behav; 2020 Dec; 10(12):e01885. PubMed ID: 33047489
[TBL] [Abstract][Full Text] [Related]
8. The roles of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) in predicting treatment remission in a Chinese Han population with generalized anxiety disorder.
Shen Z; Zhu J; Yuan Y; Ren L; Qian M; Lin M; Cai M; Zhang Z; Shen X
Psychiatry Res; 2019 Jan; 271():319-324. PubMed ID: 30529313
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A
Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
[TBL] [Abstract][Full Text] [Related]
10. Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapy.
Kobayashi K; Shimizu E; Hashimoto K; Mitsumori M; Koike K; Okamura N; Koizumi H; Ohgake S; Matsuzawa D; Zhang L; Nakazato M; Iyo M
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):658-63. PubMed ID: 15905010
[TBL] [Abstract][Full Text] [Related]
11. Pre-treatment peripheral biomarkers associated with treatment response in panic symptoms in patients with major depressive disorder and panic disorder: A 12-week follow-up study.
Kim K; Jang EH; Kim AY; Fava M; Mischoulon D; Papakostas GI; Kim H; Na EJ; Yu HY; Jeon HJ
Compr Psychiatry; 2019 Nov; 95():152140. PubMed ID: 31669792
[TBL] [Abstract][Full Text] [Related]
12. Gene×gene×gender interaction of BDNF and COMT genotypes associated with panic disorder.
Konishi Y; Tanii H; Otowa T; Sasaki T; Tochigi M; Umekage T; Motomura E; Shiroyama T; Kaiya H; Okazaki Y; Okada M
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():119-25. PubMed ID: 24508446
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of panic attack in Chinese patients with somatoform disorders.
Ma M; Shi Z; Wu H; Ma X
J Psychosom Res; 2021 Jul; 146():110509. PubMed ID: 33984592
[TBL] [Abstract][Full Text] [Related]
14. Investigating effective treatment factors in brief cognitive behavioral therapy for panic disorder.
Lim JA; Lee YI; Jang JH; Choi SH
Medicine (Baltimore); 2018 Sep; 97(38):e12422. PubMed ID: 30235717
[TBL] [Abstract][Full Text] [Related]
15. The BDNF Val66Met gene polymorphism is associated with increased alexithymic and anticipatory anxiety in patients with panic disorder.
Zou Z; Qiu J; Huang Y; Wang J; Min W; Zhou B
Psychol Health Med; 2019 Apr; 24(4):505-511. PubMed ID: 30269521
[TBL] [Abstract][Full Text] [Related]
16. CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects.
Maron E; Tõru I; Mäemets K; Sepp S; Vasar V; Shlik J; Zharkovsky A
J Psychopharmacol; 2009 Jun; 23(4):460-4. PubMed ID: 18562429
[TBL] [Abstract][Full Text] [Related]
17. Internet-Based Cognitive Behavioral Therapy With Real-Time Therapist Support via Videoconference for Patients With Obsessive-Compulsive Disorder, Panic Disorder, and Social Anxiety Disorder: Pilot Single-Arm Trial.
Matsumoto K; Sutoh C; Asano K; Seki Y; Urao Y; Yokoo M; Takanashi R; Yoshida T; Tanaka M; Noguchi R; Nagata S; Oshiro K; Numata N; Hirose M; Yoshimura K; Nagai K; Sato Y; Kishimoto T; Nakagawa A; Shimizu E
J Med Internet Res; 2018 Dec; 20(12):e12091. PubMed ID: 30559094
[TBL] [Abstract][Full Text] [Related]
18. Long-term Escitalopram Treatment in Korean Patients with Panic Disorder: A Prospective, Naturalistic, Open-label, Multicenter Trial.
Choi KW; Woo JM; Kim YR; Lee SH; Lee SY; Kim EJ; Chung SK; Kang EH; Lee JH; Yu BH
Clin Psychopharmacol Neurosci; 2012 Apr; 10(1):44-8. PubMed ID: 23429607
[TBL] [Abstract][Full Text] [Related]
19. Generalised anxiety and panic symptoms in the German National Cohort (NAKO).
Erhardt A; Gelbrich G; Klinger-König J; Streit F; Kleineidam L; Riedel-Heller SG; ; Schmidt B; Schmiedek F; Wagner M; Grabe HJ; Rietschel M; Berger K; Deckert J
World J Biol Psychiatry; 2023 Dec; 24(10):881-896. PubMed ID: 34842503
[TBL] [Abstract][Full Text] [Related]
20. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
Stahl SM; Gergel I; Li D
J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
